Original Article

Ischemic Colitis Revisited: A Prospective Study Identifying Hypercoagulability as a Risk Factor

Authors: Robin Midian-Singh, MD, Ann Polen, MED, Catherine Durishin, MD, Ronald D. Crock, MD, Frederick C. Whittier, MD, Nabil Fahmy, MD

Abstract

Background: Although causes for ischemic colitis have been identified, many cases are deemed idiopathic. Some reports suggest an association between ischemic colitis and coagulation disorders. Our purpose was to explore the relationship of ischemic colitis and clotting abnormalities.


Methods: Eighteen patients consented to undergo a hypercoagulability evaluation. Tests included protein C, protein S, activated protein C resistance, factor V Leiden, anticardiolipin antibodies, antineutrophil cytoplasmic antibodies, rheumatoid factor, antithrombin III, anti-smooth muscle antibody, lupus anticoagulant panel, and prothrombin 20210G/A mutation (in women undergoing hormone replacement therapy).


Results: Five of 18 patients tested positive for coagulation abnormalities, including factor V and activated protein C resistance, protein S deficiency, prothrombin 20210G/A mutation, and anticardiolipin antibody.


Conclusion: To our knowledge, this is the largest series of patients with ischemic colitis studied for coagulation defects in the United States. The prevalence of clotting disorders in our study (28%) was higher than that in the general population (8.4%). Coagulation disorders should be considered in some cases of ischemic colitis that are thought to be idiopathic.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Toursarkissian B, Thompson RW. Ischemic colitis. Surg Clin North Am 1997; 77: 461–470.
 
2. Nagai T, Tomizawa T, Monden T, et al. Diabetes mellitus accompanied by nonocclusive colonic ischemia. Intern Med 1998; 37: 454–456.
 
3. Arnott ID, Ghosh S, Ferguson A. The spectrum of ischaemic colitis. Eur J Gastroenterol Hepatol 1999; 11: 295–303.
 
4. Flobert C, Cellier C, Berger A, et al. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 2000; 95: 195–198.
 
5. Dowd J, Bailey D, Moussa K, et al. Ischemic colitis associated with pseudoephedrine: Four cases. Am J Gastroenterol 1999; 94: 2430–2434.
 
6. Noyer CM, Brandt LJ. Colon ischemia: Unusual aspects. Clin Perspect Gastroenterol 2000; 3: 315–326.
 
7. Mann DE Jr, Kessel ER, Mullins DL, et al. Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives. Am J Gastroenterol 1998; 93: 1960–1962.
 
8. Lucas W, Schroy PC III. Reversible ischemic colitis in a high endurance athlete. Am J Gastroenterol 1998; 93: 2231–2234.
 
9. Ludwig D, Stahl M, David-Walek T, et al. Ischemic colitis, pulmonary embolism, and right atrial thrombosis in a patient with inherited resistance to activated protein C. Dig Dis Sci 1998; 43: 1362–1367.
 
10. Koutroubakis IE, Sfiridaki A, Theodoropoulou A, et al. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology 2001; 121: 561–565.
 
11. Bennett JS. Both sides of the hypercoagulable state. Hosp Pract (Off Ed) 1997; 32: 105–121.
 
12. Bolan CD, Alving BM. Recurrent venous thrombosis and hypercoagulable states. Am Fam Physician 1991; 44: 1741–1751.
 
13. Beers MH, Berkow R (eds). The Merck Manual of Diagnosis and Therapy. Whitehouse Station, NJ, Merck, 1999, ed 17, pp 919–920.
 
14. DeLoughery TG, Goodnight SH. The hypercoagulable states: Diagnosis and management. Semin Vasc Surg 1993; 6: 66–74.
 
15. Balian A, Veyradier A, Naveau S, et al. Prothrombin 20210G/A mutation in two patients with mesenteric ischemia. Dig Dis Sci 1999; 44: 1910–1913.
 
16. Alving BM. The hypercoagulable states. Hosp Pract (Off Ed) 1993; 28: 109–121.
 
17. Grosset AB, Rodgers GM. Acquired coagulation disorders, in Lee GR, Foerster J, Lukens J, et al (eds). Wintrobe’s Clinical Hematology. Philadelphia, Lippincott Williams & Wilkins, 1999, vol 2, ed 10, pp 1759–1763.